That turn­around on new FDA drug ap­provals? We’re right on sched­ule

We were due for a pret­ty good year on new drug ap­provals from the FDA, and so far the agency and the in­dus­try have been …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.